Body Central Corp. (NASDAQ:BODY) days may be numbered if the company continues to burn millions of dollars each month. Body Central Corp (NASDAQ:BODY) shares after opening at $0.91 moved to $1.10 on last trade day and at the end of the day closed at $1.06. Company price to sales ratio in past twelve months was calculated as 0.06 and price to cash ratio as 0.87. Body Central Corp (NASDAQ:BODY) showed a negative weekly performance of -47.00%.
Trustee of Whiting USA Trust (NYSE:WHX) Warns of Possible Abrupt Substantial Decrease in Stock Price. Whiting USA Trust (NYSE:WHX) shares fell -35.06% in last trading session and ended the day on $3.50. WHX return on equity ratio is recorded as 109.30% and its return on assets is 109.30%. Whiting USA Trust (NYSE:WHX) yearly performance is -20.81%.
Stock analysts at Susquehanna reduced their price objective on shares of Leidos Holdings (NYSE:LDOS) from $45.00 to $36.00 in a report issued on Friday, AnalystRatings.Net reports. Susquehanna’s target price points to a potential upside of 124.58% from the company’s current price. Leidos Holdings, Inc. (NYSE:LDOS) shares moved down -1.59% in last trading session and was closed at $34.64, while trading in range of $34.00 – $35.50. Leidos Holdings, Inc. (NYSE:LDOS) year to date (YTD) performance is -24.99%.
Equities research analysts at Morgan Stanley assumed coverage on shares of Pharmacyclics (NASDAQ:PCYC) in a research note issued to investors on Wednesday, AR Network reports. The firm set an “equal weight” rating and a $120.00 price target on the stock. Morgan Stanley’s target price would suggest a potential upside of 14.09% from the stock’s previous close. Pharmacyclics, Inc. (NASDAQ:PCYC) weekly performance is -16.12%. On last trading day company shares ended up $100.49. Pharmacyclics, Inc. (NASDAQ:PCYC) distance from 50-day simple moving average (SMA50) is -24.19%. Analysts mean target price for the company is $165.93.